New drug candidate targeting synaptic resilience well tolerated in Alzheimer’s patients
NIA summarizes safety and biomarker findings supporting larger LM11A-31 trials.
Read release →
Targeting Endogenous Mechanisms of Brain Resilience in Alzheimer’s Disease
JPAD review frames p75NTR as a tractable resilience pathway for…
Read release →
Alzheimer’s from a New Angle
Dr. Frank Longo on hope, innovation, and a radical departure…
Read release →
Stay informed
New data, new trials, occasional essays. No more than monthly.
Unsubscribe anytime. We never share your email.